Israel Englander Myriad Genetics Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Myriad Genetics Inc stock. As of the latest transaction made, Millennium Management LLC holds 5,176,511 shares of MYGN stock, worth $79.2 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,176,511

Previous 4,399,012 17.67%

Holding current value

$79.2 Million

Previous $108 Million 31.68%

% of portfolio

0.07%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.97 - $28.6 $18.6 Million - $22.2 Million	777,499 Added 17.67%	5,176,511 $142 Million
Q2 2024 Aug 14, 2024	BUY	$17.98 - $25.47 $5.84 Million - $8.28 Million	324,974 Added 7.98%	4,399,012 $108 Million
Q1 2024 May 15, 2024	BUY	$17.59 - $23.59 $10.8 Million - $14.5 Million	612,701 Added 17.7%	4,074,038 $86.9 Million
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $35.5 Million - $54.4 Million	2,552,889 Added 281.02%	3,461,337 $66.2 Million
Q2 2023 Aug 14, 2023	SELL	$17.56 - $23.76 $8.38 Million - $11.3 Million	-476,943 Reduced 34.43%	908,448 $21.1 Million
Q1 2023 May 15, 2023	SELL	$15.26 - $23.75 $1.33 Million - $2.07 Million	-87,025 Reduced 5.91%	1,385,391 $32.2 Million
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $2.99 Million - $4.33 Million	206,181 Added 16.28%	1,472,416 $21.4 Million
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $23.1 Million - $35.3 Million	1,266,235 New	1,266,235 $24.2 Million
Q1 2022 May 16, 2022	SELL	$22.67 - $28.01 $20.1 Million - $24.8 Million	-886,758 Reduced 71.99%	344,987 $8.69 Million
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $13.8 Million - $18.7 Million	572,154 Added 86.74%	1,231,745 $34 Million
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $7.01 Million - $8.58 Million	-233,929 Reduced 26.18%	659,591 $21.3 Million
Q2 2021 Aug 16, 2021	BUY	$25.39 - $32.61 $214,723 - $275,782	8,457 Added 0.96%	893,520 $27.3 Million
Q1 2021 May 17, 2021	SELL	$19.92 - $31.6 $7.09 Million - $11.2 Million	-355,685 Reduced 28.67%	885,063 $27 Million
Q4 2020 Feb 16, 2021	BUY	$12.16 - $19.77 $1.53 Million - $2.49 Million	126,183 Added 11.32%	1,240,748 $24.5 Million
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $12.1 Million - $15.8 Million	1,071,697 Added 2499.99%	1,114,565 $14.5 Million
Q2 2020 Aug 14, 2020	SELL	$10.69 - $16.49 $149,061 - $229,936	-13,944 Reduced 24.54%	42,868 $486,000
Q1 2020 May 14, 2020	SELL	$9.78 - $29.53 $6.66 Million - $20.1 Million	-681,426 Reduced 92.3%	56,812 $813,000
Q4 2019 Feb 14, 2020	BUY	$20.93 - $35.1 $15.5 Million - $25.9 Million	738,238 New	738,238 $20.1 Million
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $37.9 Million - $80.9 Million	-1,718,033 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$22.67 - $35.0 $60.4 Million - $93.3 Million	-2,666,447 Reduced 60.82%	1,718,033 $47.7 Million
Q2 2019 Aug 14, 2019	BUY	$22.67 - $35.0 $84 Million - $130 Million	3,703,572 Added 543.92%	4,384,480 $29 Million
Q1 2019 May 14, 2019	BUY	$26.93 - $34.7 $8.87 Million - $11.4 Million	329,220 Added 93.61%	680,908 $22.6 Million
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $16.8 Million - $28 Million	-615,547 Reduced 63.64%	351,688 $10.2 Million
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $24 Million - $32.1 Million	637,481 Added 193.32%	967,235 $44.5 Million
Q2 2018 Aug 14, 2018	BUY	$27.75 - $40.17 $8.1 Million - $11.7 Million	291,902 Added 771.17%	329,754 $12.3 Million
Q1 2018 May 15, 2018	SELL	$28.83 - $41.01 $5.67 Million - $8.06 Million	-196,624 Reduced 83.86%	37,852 $1.12 Million
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $9.32 Million - $12.2 Million	-327,480 Reduced 58.28%	234,476 $8.05 Million
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $13.5 Million - $20.3 Million	561,956	561,956 $20.3 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account